Rapid Medical Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Rapid Medical Ltd. - overview
Established
2008
Location
Yokneam Illit, -, Israel
Primary Industry
Medical Devices & Equipment
About
Founded in 2008 and based in Yokneam, Israel, Rapid Medical Ltd. operates as a developer of neurovascular interventional devices. Ronen Eckhouse and Shimon Eckhouse are the co-founders of the company. In May 2021, the firm raised USD 50 million in Series D funding led by Microport Scientific Corporation including CPE Capital and Deep Insight Inc.
The company's products include Tigertriever, Tigertriever13, TigertrieverXL, which are adjustable clot retrievers for the treatment of ischemic stroke, and Comaneci, an adjustable remodeling mesh for the treatment of brain aneurysm, and also Columbus, a steerable guidewire. The organization is committed to advancing patient care by providing reliable, easy to use and high-quality products proven by clinical data. Rapid Medical plans to use the May 2021 funding to support the fast commercial growth of the company’s minimally invasive stroke products worldwide and to expand commercial operations in the US and Europe, and also for regulatory approvals in new strategic territories such as China.
Current Investors
BRM Group, Winnovation, Gefen Capital
Primary Industry
Medical Devices & Equipment
Sub Industries
Biotechnology, Medical Devices & Equipment
Website
www.rapid-medical.com
Company Stage
Series D
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.